Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cannabidiol May Interact With Rheumatologic Drugs

Publish date:: September 16, 2019

Key clinical point: Patients need to be asked directly about “drugs considered alternative medicines and food supplements.”

Major finding: Drugs such as hydrocortisone, naproxen, tramadol, and tofacitinib may interact with CBD oil.

Study details: Literature search that included use of the British National Formulary and the Natural Medicines online interaction checker.

Disclosures: The investigators declared no conflicts of interest, and there was no specific funding for the study.

Citation:

Wilson-Morkeh H et al. Rheumatology. 2019 July 29. doi: 10.1093/rheumatology/kez304.

This Week's Must Reads

Osteoporosis prevalence in PsA similar to general population,

Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases,

Weight loss may be paramount lifestyle change in preventing gout,

Gut microbiome influences response to methotrexate in new-onset RA patients,

Early treatment of RA with DMARDs promotes sustained remission,

Must Reads in Ankylosing spondylitis

Etanercept may not help some with suspected nonradiographic axial spondyloarthritis,

Novel study explores link between primary immunodeficiencies, rheumatic diseases,

Lower TNF inhibitor efficacy observed in women with nonradiographic axSpA,

Shingrix effective in older adults with preexisting immune-mediated disorders,

Trabecular bone loss may contribute to axial spondyloarthritis progression,